Home  »  Companies   »  Observations on the NRx Pharmaceuticals Inc. (NASD...

Observations on the NRx Pharmaceuticals Inc. (NASDAQ:NRXP) Growth Curve

Currently, NRx Pharmaceuticals Inc.’s (NRXP) stock is trading at $0.54, marking a gain of 6.03% from last night’s close. At this price, the stock is -97.92% below its 52-week high of $26.24 and 11.19% above its 52-week low of $0.49. Based on the past 30-day period, the stock price is -68.20% below the high and +9.06% above the low.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, NRXP’s SMA-200 is $5.0553.

NRXP’s price to book ratio for the most recent quarter was 1.03, resulting in an 0.86 price to cash per share for the period.

How does NRx Pharmaceuticals Inc. (NRXP) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Ownership Details

I will give a breakdown of the key shareholders in NRx Pharmaceuticals Inc. (NRXP). Recent figures show that the company’s insiders hold 47.42% of shares. A total of 49 institutional investors hold shares in the company, making 16.36% of its stock and 31.12% of its float.

Mar 30, 2022, it was reported that the Company’s largest institutional holder is Armistice Capital, LLC holding total of 6.26 million shares that make 9.39% of the company’s total number of shares and are currently priced at 15.34 million.

The securities firm Vanguard Group, Inc. (The) holds 1.08 million shares of NRXP, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 1.61%, and the holding percentage of shares is valued at 2.63 million.

An overview of NRx Pharmaceuticals Inc.’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests NRx Pharmaceuticals Inc. (NRXP) traded 2,666,268 shares per day, with a moving average of $0.8948 and price change of -0.83. With the moving average of $1.4544 and a price change of -1.89, about 1,351,333 shares changed hands on average over the past 50 days. Finally, NRXP’s 100-day average volume is 1,084,370 shares, alongside a moving average of $2.1800 and a price change of -3.08.

Leave a Comment

Your email address will not be published.

Related Posts




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam